Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 237,717 |
|
|||||
| News | - | ||||||
| Day High | 1.62 | Low High |
|||||
| Day Low | 1.45 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Iterum Therapeutics PLC | ITRM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.07 | 4.58% | 1.60 | 14:59:52 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.51 | 1.45 | 1.62 | 1.60 | 1.53 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 447 | 237,717 | US$ 1.52 | US$ 361,085 | - | 0.622 - 2.64 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 375 | US$ 1.59 | USD |
Iterum Therapeutics PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 21.5M | 13.44M | - | 503k | -43.67M | -3.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Iterum Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/29/2024 | 07:00 | GlobeNewswire Inc. | Iterum Therapeutics Resubmits New Drug Application to U.S... |
| 3/28/2024 | 06:42 | IH Market News | US Stock Futures Stable in Pre-Market On Path for.. |
| 3/28/2024 | 06:00 | GlobeNewswire Inc. | Iterum Therapeutics Reports Fourth Quarter and Full Year.. |
| 3/21/2024 | 15:30 | GlobeNewswire Inc. | Iterum Therapeutics to Report Fourth Quarter and Full Year.. |
| 3/15/2024 | 07:00 | GlobeNewswire Inc. | Iterum Therapeutics to Participate in H.C. Wainwright.. |
| 3/06/2024 | 07:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/06/2024 | 07:00 | GlobeNewswire Inc. | Iterum Therapeutics Provides Business Update |
| 1/30/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/30/2024 | 06:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/30/2024 | 06:00 | PR Newswire (US) | Iterum Therapeutics Announces Positive Topline Results from.. |
| 12/29/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/14/2023 | 06:45 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITRM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.60 | 1.75 | 1.45 | 1.56 | 172,509 | 0.00 | 0.00% |
| 1 Month | 1.58 | 1.93 | 1.42 | 1.65 | 159,598 | 0.02 | 1.27% |
| 3 Months | 1.73 | 1.93 | 1.2197 | 1.54 | 196,975 | -0.13 | -7.51% |
| 6 Months | 0.651 | 2.64 | 0.651 | 1.61 | 399,963 | 0.949 | 145.78% |
| 1 Year | 1.18 | 2.64 | 0.622 | 1.55 | 218,517 | 0.42 | 35.59% |
| 3 Years | 1.20 | 3.1305 | 0.175 | 0.9823338 | 2,467,228 | 0.40 | 33.33% |
| 5 Years | 8.25 | 8.25 | 0.175 | 1.35 | 3,473,602 | -6.65 | -80.61% |
Iterum Therapeutics Description
| Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. |
